Loading…
← CockpitCompetitor Analysis › AYA.AX Artrya LimitedOpen in the cockpit ↗

Artrya LimitedAYA.AXCompetitor analysis, valuation and peers

Australia · AUD·Information Technology›Packaged Software
Momentum laggard 10
Mkt cap
$285M
US dollars, full cap
Free float
80%
of shares outstanding
$/day
$2.31M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
n/a
WACC 14.4%
Hurdle
n/a
no reverse DCF
Next earnings
104 days
2 Mar 2027
Close · AUDA$2.70
1D-6.9%
1W-24.6%
1M+6.3%
3M-44.3%
6M-42.7%
YTD-42.7%
1Y-14.8%
ATR %11.2%
52w lowhigh58.4% off high

What Artrya does

No business profile yet.

Artrya at a glance

Size Artrya (AYA.AX) is an Australia Information Technology company (Packaged Software) with a market value of $285M, the 316th largest of 317 Australia companies the cockpit tracks. Shares closed at A$2.70 on 18 Nov 2026.

Performance Over six months the shares fell 42.7%, against -24.5% for the median peer and +1.2% for the Australia market (cap-weighted) — 5th lowest of 20 in its peer set.

Growth Revenue was unchanged over the last twelve months (peer median +18.1%); the operating margin is -97,478.6% (peer median 3.8%).

Valuation It trades at 12,568.9× enterprise value to sales against a peer median of 3.8× (most expensive of 20).

Next results Next results expected around 2 Mar 2027 (exchange calendar; dates can move).

Relative performance

507510012521 May 202621 Aug 202618 Nov 2026Peer median 75AYA.AX 58
Six months, rebased to 100: Artrya against the median of its 20 peers (local-currency closes).

Artrya financials

Reported figures in AUD; fiscal year ends 2026-06-30. TTM = trailing twelve months.
TTMFY2026FY2025FY2024FY2023
RevenueA$28,000A$28,000A$28,000A$0A$0
Revenue growth—0%———
Gross profit-A$1.23M-A$1.23M-A$1.17M-A$2.00M-A$552,000
EBITDA-A$26.0M-A$26.0M-A$20.5M-A$16.1M-A$11.9M
Net income-A$25.2M-A$25.2M-A$16.4M-A$14.0M-A$11.1M
Free cash flow-A$15.9M-A$15.9M-A$14.3M-A$15.0M-A$11.0M
Capital expenditureA$500,000A$500,000A$263,000A$46,000A$5.95M
Total debtn/aA$247,000A$624,000A$949,000A$1.21M

Quarterly statements and history in the cockpit →

Artrya competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-25%0%+25%+50%688081688078CBRAINABXX4259688201301159SFASUR603189ALBFREGHTCRNCNET300419EMUDHRA2576490470AYA.AX6-month return →1-month return →
Up and to the right = strong over both horizons. Artrya is the large dot.

Fundamentals: revenue growth against valuation

0%+100%+200%+300%0×5,000×10,000×688081688078CBRAINABXX4259603189AYA.AXRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Artrya is the large dot.

Artrya competitors and peer comparison

How Artrya compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Artrya against its 20 peers (data as of 18 Nov 2026)
MeasureAYA.AXPeer medianRank in peer set
1-month return+6.3%-12.5%4th highest of 21
6-month return-42.7%-24.5%5th lowest of 20
Distance from 52-week high-58.4%-47.4%8th lowest of 21
Revenue growth (TTM)0.0%+18.1%7th lowest of 20
Operating margin-97,478.6%3.8%lowest of 20
EV / Sales12,568.9×3.8×most expensive of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Artrya AYA.AXAustralia$285M-43%0%-97,479%12,568.9×n/an/a
Einride AB Sponsored ADR ENRDUnited States$288Mn/an/an/an/an/an/a
Wuhan Xingtu Xinke Electronics 688081.SSChina$289M-65%-18%-45%13.7×n/an/a
Beijing Longruan Technologies 688078.SSChina$295M+8%-43%-71%11.6×49.0%-4.8%
cBrain A/S CBRAIN.CODenmark$296M+73%-1%24%7.8×10.2%+15.9%
Abaxx Technologies ABXX.TOCanada$302M-83%+319%-3,344%162.7×n/an/a
ExaWizards 4259.TJapan$308M-45%+34%11%3.1×36.9%+35.6%
Beijing Infosec Technologies 688201.SSChina$311M-25%+1%-3%4.0×47.8%+5.5%
Beijing SunwayWorld Science & Technology 301159.SZChina$313M-30%+18%4%4.7×40.3%+7.0%
Stillfront SF.STSweden$313M+15%-12%16%1.3×-15.4%+7.4%
Asure Software ASURUnited States$313M+19%+21%1%2.3×43.9%+16.5%
Shanghai WonderTek Software 603189.SSChina$314M-42%+43%-7%3.8×n/an/a
Sidetrade ALBFR.PAFrance$314M+18%+13%5%4.4×33.8%+16.1%
8x8 EGHTUnited States$315M-4%+4%4%0.8×10.0%+6.7%
Cerence CRNCUnited States$316M-24%+26%12%1.2×3.5%-5.3%
Hangzhou Yitong New Materials 300930.SZChina$317M-34%+51%7%2.5×n/an/a
Netcall NET.LUnited Kingdom$317M+13%+20%10%3.8×10.8%+16.3%
Beijing Interact Technology 300419.SZChina$256M-28%-52%-54%11.8×29.3%-17.8%
eMudhra EMUDHRA.NSIndia$318M-23%+30%18%4.0×n/an/a
Zhejiang Taimei Medical Technology 2576.HKHong Kong$318M-4%-7%-14%2.4×n/an/a
SemiFive 490470.KSSouth Korea$319M-65%+50%-22%2.0×n/an/a

Questions

Which companies are Artrya's closest peers?
The cockpit's peer set: Einride AB Sponsored ADR (ENRD), Wuhan Xingtu Xinke Electronics (688081.SS), Beijing Longruan Technologies (688078.SS), cBrain A/S (CBRAIN.CO), Abaxx Technologies (ABXX.TO), ExaWizards (4259.T), Beijing Infosec Technologies (688201.SS), Beijing SunwayWorld Science & Technology (301159.SZ).
Is Artrya expensive compared with its peers?
On ev / sales it trades at 12,568.9× against a peer median of 3.8×, most expensive of 20 in its peer set.
How has Artrya stock performed?
Over six months to 18 Nov 2026 the shares returned -42.7% against -24.5% for the median peer; over one year -14.8%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.